News | January 25, 2012

First Hospital in India Installs Advanced TrueBeam Radiotherapy Treatment System

January 25, 2012 — A 65-year-old breast cancer patient has become the first person in India to be treated using the fast and precise TrueBeam radiotherapy treatment system from Varian Medical Systems. In a treatment carried out at Health Care Global (HCG) Ahmedabad, the patient received accelerated partial breast irradiation that allowed her treatment course to be completed in a week instead of the usual five weeks required with previous Varian technology.

"The patient was saved from visiting hospital for five full weeks," says radiation oncologist Dr. Vivek Bansal. "As the TrueBeam treatment involved high dose rates delivered twice a day, the clinical team needed to be certain that the intended dose was delivered to the right area. A high degree of accuracy and good quality imaging helped ensure successful completion of the treatment."

Bansal said shorter treatment times, high quality imaging and greater throughput were all significant benefits for patients and the clinical team at HCG Ahmedabad. The center, which added radiotherapy to existing surgical and chemotherapy services a month ago, is the first private cancer hospital in Ahmedabad offering both diagnostic and treatment facilities for cancer under one roof. Its patients come from across Gujarat and neighbouring states of Rajasthan and Madhya Pradesh, as well as from outside India.

Bansal and his team intend to use the TrueBeam device, which was installed in October, to deliver advanced radiotherapy techniques such as stereotactic body radiotherapy (SBRT) treatments, as well as carrying out clinical studies and research programs.

Designed to advance the treatment of lung, breast, prostate, gynecologic, liver, head and neck, and other types of cancer, the TrueBeam platform for image-guided radiotherapy and radiosurgery is a fully-integrated radiotherapy system designed from the ground up to treat a moving target, such as a tumor, with speed and precision. It features a High Intensity Mode—one of six dose levels available to doctors with the TrueBeam platform—for customizing dose delivery based on a patient's specific tumor characteristics.

High Intensity Mode has yet to receive clearance in India, but it is cleared by the U.S. Food and Drug Administration (FDA), has CE marking and regulatory clearances in all other major markets.

For more information: www.varian.com

Related Content

iCAD Reports Strong Momentum of ProFound AI for Digital Breast Tomosynthesis
News | Artificial Intelligence | March 26, 2019
iCAD Inc. reported strong adoption of its latest deep-learning, cancer detection software solution for digital breast...
Volpara Solutions Expands Relationship With GE Healthcare
News | Breast Density | March 26, 2019
Volpara Solutions announced the launch of an expanded agreement enabling the worldwide distribution of its...
Hologic Opens Learning and Experience Centre in Zaventem, Belgium
News | Women's Health | March 21, 2019
Hologic Inc. opened its first Learning and Experience Centre in Zaventem, Belgium. The state-of-the-art facility...
QTbreasthealth Opens Breast Imaging Center in San Jose
News | Ultrasound Women's Health | March 20, 2019
QTbreasthealth has opened a new center in San Jose, Calif. The new location is now open and booking appointments for...
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...